IL-17A Differentially Regulates Corneal Vascular Endothelial Growth Factor (VEGF)-A and Soluble VEGF Receptor 1 Expression and Promotes Corneal Angiogenesis after Herpes Simplex Virus Infection
- 1 April 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 188 (7) , 3434-3446
Abstract
Ocular infection with HSV causes corneal neovascularization (CV), an essential step in the pathogenesis of the blinding immunoinflammatory lesion stromal keratitis. The infection results in IL-17A production, which contributes to CV in ways that together serve to shift the balance between corneal concentrations of vascular endothelial growth factor A (VEGF-A) and the soluble vascular endothelial growth factor receptor 1 molecule, which binds to VEGF-A and blocks its function (a so-called VEGF trap). Accordingly, animals lacking responses to IL-17A signaling, either because of IL-17 receptor A knockout or wild-type animals that received neutralizing mAb to IL-17A, had diminished CV, compared with controls. The procedures reduced VEGF-A protein levels but had no effect on the levels of soluble vascular endothelial growth factor receptor 1. Hence the VEGF trap was strengthened. IL-17A also caused increased CXCL1/KC synthesis, which attracts neutrophils to the inflammatory site. Neutrophils further influenced the extent of CV by acting as an additional source of VEGF-A, as did metalloproteinase enzymes that degrade the soluble receptor, inhibiting its VEGF-blocking activity. Our results indicate that suppressing the expression of IL-17A, or increasing the activity of the VEGF trap, represents a useful approach to inhibiting CV and the control of an ocular lesion that is an important cause of human blindness.Keywords
This publication has 57 references indexed in Scilit:
- VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesisJournal of Experimental Medicine, 2009
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayJournal of Experimental Medicine, 2009
- Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responsesMicrobes and Infection, 2008
- Structure–function relationships in the IL-17 receptor: Implications for signal transduction and therapyCytokine, 2008
- Innate Recognition Network Driving Herpes Simplex Virus-Induced Corneal Immunopathology: Role of the Toll Pathway in Early Inflammatory Events in Stromal KeratitisJournal of Virology, 2007
- Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cellsProceedings of the National Academy of Sciences, 2006
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- The biology of VEGF and its receptorsNature Medicine, 2003
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993